← All trials
NCT03815448
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2019
- Primary completion
- Dec 31, 2020
- Completion date
- Dec 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Southern Medical UniversityLead sponsor
- Anhui Medical UniversityCollaborator
- Harbin Medical UniversityCollaborator
- Southern Medical UniversityReponsible party - principal investigator
- Chinese Academy of Medical SciencesCollaborator
- Peking UniversityCollaborator
- Capital Medical UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- The Second People's Hospital of GuangDong ProvinceCollaborator
- Southern Medical UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.